Author:
Sharma Supriya,Acharya Jyoti,Caugant Dominique A.,Thapa Jeewan,Bajracharya Manju,Kayastha Madhusudan,Sharma Saroj,Chalise Bimal S.,Karn Ragesh,Banjara Megha R.,Ghimire Prakash,Singh Anjana
Abstract
Background:
The global epidemiology of meningococcal disease varies markedly by region and over time. In Nepal, information on serogroup of meningococci is not available since the 1983 serogroup A epidemic in Kathmandu.
Objective:
To provide some fundamental data on the circulating serogroups of meningococci for potential meningococcal immunization programs in Nepal.
Methods:
This cross-sectional prospective study was conducted from January 2017 to December 2018 among 387 clinically suspected meningitis cases. Cerebrospinal fluid samples were collected by lumbar puncture technique at five referral hospitals of Kathmandu and processed by conventional cultural techniques. Neisseria meningitidis was identified by colony morphology, Gram staining and oxidase test. Serogrouping of meningococci was performed by slide agglutination test. Antibiotic susceptibility testing was done by the modified Kirby Bauer disc diffusion method. The data was entered into IBM SPSS Statistics 21 software and a p-value of <0.05 was considered significant.
Results:
Thirty-two samples were positive by culture for a bacterial pathogen with 2.3% of meningococci. All except one meningococcal meningitis cases were aged below 15 years. All N.meningitidis isolates belonged to serogroup A and were susceptible to ceftriaxone, chloramphenicol, meropenem and minocycline; however, 22% isolates showed resistance to cotrimoxazole and 11% intermediate resistance to ciprofloxacin.
Conclusion:
The circulating serogroup of N. meningitidis in Kathmandu has not changed over the past 35 years. The prevalence of meningococcal meningitis in Kathmandu is low but might be underestimated due to the sole use of culture-based diagnostic methods. Detection of meningococci by alternative methods may be useful in the precise estimation of actual disease burden.
Publisher
Bentham Science Publishers Ltd.
Subject
General Immunology and Microbiology
Reference41 articles.
1. Jafri RZ, Ali A, Messonnier NE, et al.
Global epidemiology of invasive meningococcal disease.
Popul Health Metr
2013;
11
(1)
: 17.
2. Crum-Cianflone N, Sullivan E.
Meningococcal vaccinations.
Infect Dis Ther
2016;
5
(2)
: 89-112.
3. CDC. Meningococcal Disease. Centers for Disease Control and Prevention; 2016; Available from: .
https://www.cdc.gov /meningococcal/index.html
4. Vyse A, Wolter JM, Chen J, Ng T, Soriano-Gabarro M.
Meningococcal disease in Asia: an under-recognized public health burden.
Epidemiol Infect
2011;
139
(7)
: 967-85.
[Review].
5. Cochi SL, Markowitz LE, Joshi DD, et al.
Control of epidemic group A meningococcal meningitis in Nepal.
Int J Epidemiol
1987;
16
(1)
: 91-7.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献